SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-22-001922
Filing Date
2022-08-16
Accepted
2022-08-16 16:52:49
Documents
83
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q axim_10q.htm   iXBRL 10-Q 1611048
2 CERTIFICATION axim_ex311.htm EX-31.1 10162
3 CERTIFICATION axim_ex312.htm EX-31.2 10538
4 CERTIFICATION axim_ex321.htm EX-32.1 3931
5 CERTIFICATION axim_ex322.htm EX-32.2 3890
11 axim_10qimg2.jpg GRAPHIC 5134
  Complete submission text file 0001096906-22-001922.txt   7393199

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA axim-20220630.xsd EX-101.SCH 89011
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE axim-20220630_lab.xml EX-101.LAB 466411
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axim-20220630_cal.xml EX-101.CAL 44960
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axim-20220630_pre.xml EX-101.PRE 399688
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axim-20220630_def.xml EX-101.DEF 257723
77 EXTRACTED XBRL INSTANCE DOCUMENT axim_10q_htm.xml XML 926378
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 221170830
SIC: 2834 Pharmaceutical Preparations